QWP
GILD icon

Quotient Wealth Partners’s Gilead Sciences GILD Stock Holding History

Quotient Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.31M Sell
10,395
-205
-2% -$27K 0.03% 116
2026
Q1 		$1.48M Buy
10,600
+1,599
+18% +$224K 0.04% 98
2025
Q4 		$1.1M Sell
9,001
-119
-1% -$14.5K 0.03% 114
2025
Q3 		$1.01M Buy
9,120
+1,073
+13% +$122K 0.03% 117
2025
Q2 		$892K Buy
8,047
+577
+8% +$61.4K 0.03% 127
2025
Q1 		$837K Sell
7,470
-859
-10% -$88.6K 0.03% 123
2024
Q4 		$769K Sell
8,329
-70
-0.8% -$6.3K 0.03% 129
2024
Q3 		$704K Buy
8,399
+95
+1% +$7.25K 0.02% 141
2024
Q2 		$570K Sell
8,304
-1,846
-18% -$123K 0.02% 160
2024
Q1 		$743K Sell
10,150
-641
-6% -$49.3K 0.03% 135
2023
Q4 		$874K Buy
+10,791
New +$840K 0.03% 133

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Quotient Wealth Partners's GILD Position: Q2 2026 in Review

Quotient Wealth Partners reduced its Gilead Sciences (GILD) stake by 1.9% in Q2 2026, selling an estimated $27K and leaving 10,395 shares worth $1.31M. The position accounts for 0.03% of the portfolio, ranked #116.

Quotient Wealth Partners first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.48M in Q1 2026. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Quotient Wealth Partners held 10,395 shares of Gilead Sciences worth $1.31M as of Q2 2026.
  • Quotient Wealth Partners sold 205 Gilead Sciences shares in Q2 2026, an estimated $27K.
  • Gilead Sciences made up 0.03% of Quotient Wealth Partners's portfolio in Q2 2026, its #116 holding.
  • Quotient Wealth Partners first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
  • Quotient Wealth Partners's Gilead Sciences position peaked at $1.48M in Q1 2026.
  • 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Quotient Wealth Partners's 13F filing for Q2 2026, filed 3 Aug 2026.